Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Q4 2021 vs. Q3 2021
How the institutions holding Lakefront Biotherapeutics NV changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 81 | 2 | 83 | +4 |
| Shares | 8.55M | 2.26K | 10.8M | +2.25M (+26.3%) |
| Value | $449.8M | $119.0K | $595.0M | +$145.3M (+32.3%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Great Point Partners LLC | 300,000 | $16.5M | 3.70% |
| Greenlight Capital Inc | 185,000 | $10.2M | 0.62% |
| Paradigm Biocapital Advisors LP | 167,824 | $9.25M | 2.64% |
| Silverarc Capital Management, LLC | 128,901 | $7.11M | 3.18% |
| Monaco Asset Management SAM | 97,064 | $5.35M | 3.35% |
| Alps Advisors Inc | 76,280 | $4.21M | 0.05% |
| Brookfield Asset Management Inc. | 66,805 | $3.68M | 0.01% |
| Schonfeld Strategic Advisors LLC | 43,426 | $2.39M | 0.02% |
| Carlson Capital L P | 40,000 | $2.21M | 0.13% |
| Caption Management, LLC | 30,000 | $1.65M | 0.10% |
| Cinctive Capital Management LP | 28,100 | $1.55M | 0.07% |
| J. Goldman & Co LP | 27,972 | $1.54M | 0.14% |
| Prelude Capital Management, LLC | 22,505 | $1.24M | 0.06% |
| Alliancebernstein L.P. | 20,000 | $1.10M | 0.00% |
| Wellington Management Group LLP | 16,282 | $898.0K | 0.00% |
| Knott David M Jr | 7,000 | $386.0K | 0.15% |
| Marshall Wace, LLP | 6,225 | $344.0K | 0.00% |
| Aquatic Capital Management LLC | 2,000 | $110.0K | 0.21% |
| CWM, LLC | 8 | $0 | 0.00% |
Sold out (15)
Institutions that held Lakefront Biotherapeutics NV at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Stonepine Capital Management, LLC | 244,205 | $12.8M |
| Canada Pension Plan Investment Board | 57,100 | $3.00M |
| HRT Financial LP | 39,608 | $2.08M |
| Jump Financial, LLC | 29,817 | $1.57M |
| Susquehanna Fundamental Investments, LLC | 28,551 | $1.50M |
| Affinity Asset Advisors, LLC | 20,000 | $1.05M |
| PointState Capital LP | 17,500 | $921.0K |
| Continental Advisors LLC | 10,000 | $526.0K |
| DekaBank Deutsche Girozentrale | 2,760 | $137.0K |
| Group One Trading, L.P. | 2,368 | $125.0K |
| Erste Asset Management GmbH | 1,700 | $88.7K |
| Harbour Investments, Inc. | 408 | $21.0K |
| Penserra Capital Management LLC | 215 | $11.0K |
| Assetmark, Inc | 171 | $9.00K |
| Arkadios Wealth Advisors | 29 | $1.00K |
Not filed for Q4 2021 yet (2)
Institutions that held Lakefront Biotherapeutics NV at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 2,000 | $105.0K |
| Wealth Quarterback LLC | 264 | $14.0K |